New cancer drug shows promise in early trial
NCT ID NCT02952248
First seen Jan 31, 2026 · Last updated Apr 29, 2026 · Updated 12 times
Summary
This early-phase trial tested a new drug called BI 754091 in 110 adults with advanced solid tumours that could not be removed by surgery or had spread. The main goal was to find a safe dose and check for side effects. Researchers also looked for signs that the drug might shrink tumours, but this is not a cure and ongoing treatment is expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, H2X 0A9, Canada
-
Florida Cancer Specialists
Sarasota, Florida, 34232, United States
-
Greenville Health System
Greenville, South Carolina, 29605, United States
-
Ingalls Memorial Hospital
Harvey, Illinois, 60426, United States
-
Juravinski Cancer Centre - Hamilton Health Sciences
Hamilton, Ontario, L8V 5C2, Canada
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
Sarah Cannon Research Institute
London, W1G 6AD, United Kingdom
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73104, United States
-
Tennessee Oncology, PLLC
Nashville, Tennessee, 37203, United States
-
The Christie Hospital
Manchester, M20 4BX, United Kingdom
-
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.